Titrimetric analysis with catalytic end-point detection and a spotting technique
β Scribed by Herbert Weisz; Joachim Schlipf
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 519 KB
- Volume
- 147
- Category
- Article
- ISSN
- 0003-2670
No coin nor oath required. For personal study only.
β¦ Synopsis
In the determinations described, the catalyst is usually titrated with the inhibitor. A semi-automatic spotting method is used for end-point detection. Dilute solutions of metal ions (Cu, Fe, Co, Ni, Zn, Al, Fe + Ni, Fe + Al), usually in the range 3-70 pg ml-', are titrated with EDTA solutions. Mixtures of iodide (3-25 mg) and chloride (2-15 mg) are titrated sequentially with 1 M silver nitrate solution to different catalytic end-points. A minute proportion of the solution being titrated is transferred continuously to a mixing chamber where it reacts with suitable indicator solutions and drops onto a moving band, on which the end-point can be recognized by a colour change in successive drops. Calibration graphs are essential.
π SIMILAR VOLUMES
## Abstract Look and Locker's singleβscan, multipleβpoint, __T__~1~ determination technique modified for imaging applications was evaluated experimentally for its accuracy and reliability with respect to the pulse sequence parameters. in particular. to the interpulse delay, __T__~D~, and the tip an
To gain new insights into the pathogenesis of hepatitis B virus-induced chronic liver disease, we have used nonisotopic in situ detection methods for the simultaneous analysis of hepatitis B virus DNA and antigens at the single-cell level. Paraffin-embedded liver specimens from 23 cirrhotic patients
This study is a systematic review and meta-analysis of studies using nucleic acid-based techniques to detect Mycobacterium avium paratuberculosis (MAP) in patients with Crohn's disease (CD) compared with controls. Database searches were conducted and risk difference estimates were calculated using m
## Abstract ## Background The initial response to induction therapy is currently considered one of the most important prognostic factors in acute lymphoblastic leukemias (ALL). A series of methods for the detection of submicroscopic levels of residual disease in patients with ALL mainly based on P